Dirksen, Uta
Essen University Hospital
7 papers on CoChatORCID 0000-0002-5435-7860
Most cited papers
- Verified
The landscape of genomic alterations across childhood cancers
ICGC PedBrain-Seq Project, Gröbner, S. N., ICGC MMML-Seq Project, Worst, B. C., Weischenfeldt, J., Buchhalter, I., Kleinheinz, K., Rudneva, V. A., Johann, P. D., Balasubramanian, G. P., et al. (2018) · Nature
Cancer Genomics and DiagnosticsChromatin Remodeling and Cancer
Cited by 1,572
- Verified
Ewing sarcoma
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers
Sarcoma Diagnosis and TreatmentChromatin Remodeling and Cancer
Cited by 873
- Verified
Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden
Peneder, P., Stütz, A. M., Surdez, D., Krumbholz, M., Semper, S., Chicard, M., Sheffield, N. C., Pierron, G., Lapouble, E., Tötzl, M., et al. (2021) · Nature Communications
Cancer Genomics and DiagnosticsSarcoma Diagnosis and Treatment
Cited by 200
- Verified
Phase III assessment of topotecan and cyclophosphamide and high-dose ifosfamide in rEECur: An international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES).
McCabe, M., Kirton, L., Khan, M., Fenwick, N., Strauss, S. J., Valverde, C., Mata, C., Gaspar, N., Luksch, R., Longhi, A., et al. (2022) · Journal of Clinical Oncology
Sarcoma Diagnosis and TreatmentAcute Lymphoblastic Leukemia research
Cited by 46
- Verified
Quantification of Translocation-Specific ctDNA Provides an Integrating Parameter for Early Assessment of Treatment Response and Risk Stratification in Ewing Sarcoma
Krumbholz, M., Eiblwieser, J., Ranft, A., Zierk, J., Schmidkonz, C., Stütz, A. M., Peneder, P., Tomazou, E. M., Agaimy, A., Bäuerle, T., et al. (2021) · Clinical Cancer Research
Sarcoma Diagnosis and TreatmentCancer Genomics and Diagnostics
Cited by 39
- Verified
Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone
Isfort, I., Elges, S., Cyra, M., Berthold, R., Renner, M., Mechtersheimer, G., Åman, P., Larsson, O., Ratner, N., Hafner, S., et al. (2019) · Scientific Reports
Hippo pathway signaling and YAP/TAZSarcoma Diagnosis and Treatment
Cited by 35
- Verified
Correction to: Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA
Schmidkonz, C., Krumbholz, M., Atzinger, A., Cordes, M., Goetz, T. I., Prante, O., Ritt, P., Schaefer, C., Agaimy, A., Hartmann, W., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging
Sarcoma Diagnosis and TreatmentMedical Imaging Techniques and Applications
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free